| Aarkstore announce a new report "Small Medium | | | | 1 Table of Contents |
| Enterprises: The Powerhouse of Innovation for Medical | | | | 1 Table of Contents 2 |
| Device Industry" through its vast collection of market | | | | 1.1 List of Tables 4 |
| research report. | | | | 1.2 List of Figures 5 |
| Small Medium Enterprises: The Powerhouse of | | | | 2 GlobalData Viewpoint 6 |
| Innovation for Medical Device Industry | | | | 2.1 Summary 6 |
| Summary | | | | 2.2 The global medical technology industry is |
| Rapid innovation is a pre-condition for survival of | | | | dominated by SMEs; 95% of the total number of |
| medical device companies, given the quick turnaround | | | | medical equipment companies are SMEs 7 |
| time of the product innovation cycle. Aging population | | | | 2.2.1 Bulk of the small and medium businesses in |
| and swelling healthcare expenditures across the world | | | | medical technology are headquartered in North |
| are pushing medical device companies to find cost | | | | America and Europe 9 |
| efficiencies and bring down product costs, again putting | | | | 2.3 SMEs are an Important Contributor to a |
| pressure on speedy innovation. | | | | Country’s Economy 10 |
| Small and medium business enterprises (SMEs) have | | | | 2.4 SMEs Are a Major Source of Innovation and |
| traditionally played a crucial role in the development of | | | | Account for Bulk of Pipeline Products in the Medical |
| new products in the biotech and medical device | | | | Device Sector 10 |
| industry. These firms due to their quick adaptability, | | | | 2.4.1 Majority of pipeline products in medical technology |
| ability to identify market niches, and considerable | | | | are developed by SMEs 11 |
| innovative potential form an important component of | | | | 2.4.2 In-Vitro diagnostics, cardiology and orthopedics |
| the healthcare industry worldwide. Accounting for | | | | are the most common focus areas being developed |
| more than 50% of all pipeline products, they have a | | | | by SMEs 11 |
| significant role in the future of healthcare industry. | | | | 2.5 SMEs Depend on Various Funding Sources, Which |
| Analysis of 3,988 products currently in pipeline reveals | | | | are Under Pressure Due to Recession 15 |
| that 56% of them are being developed by small | | | | 2.5.1 Government Plays an Important Role in Providing |
| businesses. By 2008, 95% of the medical device | | | | Access to Funding 17 |
| sector was comprised of SMEs. Moreover, analysis of | | | | 2.5.2 Funding provided by VCs and PEs Hit Due to |
| 1914 pipeline products revealed more than 80% of all | | | | Recession 18 |
| products being developed by companies | | | | 2.5.3 Sluggish IPO Market Hits Growth Stage |
| headquartered in the US. | | | | Companies 18 |
| Most of new product development activity was | | | | 2.5.4 Despite Increased Focus on SMEs, Gaps Remain |
| observed in high growth therapy areas such as in-vitro | | | | in Funding 19 |
| diagnostics, cardiology and orthopedics. 59% of all | | | | 2.6 Provision of Risk Capital through Government |
| pipeline products developed by SMEs were focused in | | | | Support and Industry Collaboration Required to |
| these therapy areas. This is in line with medical device | | | | Promote SME Growth in the Future 19 |
| companies trying to capitalize on the aging population in | | | | 3 Appendix 21 |
| key markets such as US and Europe. Improving cost | | | | 3.1 GlobalData Research Methodology 21 |
| efficiency and reducing healthcare costs are few of | | | | 3.2 Secondary Research 22 |
| the key factors driving the new product development | | | | 3.3 Primary Research 23 |
| in diagnostics, home monitoring and minimal invasive | | | | 3.4 Models 23 |
| technology. | | | | 3.5 Forecasts 24 |
| Scope | | | | 3.6 Expert Panel Validation 24 |
| - The study talks about the recent developments in | | | | 3.7 Currency Conversion 25 |
| the medical device industry and the impact of small | | | | 3.8 Contact Us 26 |
| medium enterprises (SMEs) on the market. | | | | 3.9 Disclaimer 26 |
| - It provides information on the composition of the | | | | 1.1 List of Tables |
| medical device industry in North America and Europe. | | | | Table 1: Pipeline Analysis of SMEs 13 |
| - It also discusses briefly about the geographic | | | | Table 2: USD to Local Currency, Average Exchange |
| break-up of SME medical devices, the share of pipeline | | | | Rate 2008 25 |
| products developed by SMEs and the pipeline analysis | | | | 1. |
| of SMEs. | | | | |